The truth about Tamiflu?

Data access is matter of trust

BMJ 2010; 340 doi: 10.1136/bmj.c134 (Published 13 January 2010)
Cite this as: BMJ 2010;340:c134

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Alan R Maryon-Davis, president1
  1. 1UK Faculty of Public Health, London NW1 4LB
  1. president{at}fph.org.uk

    The UK Faculty of Public Health strongly supports the BMJ’s call for mandatory disclosure of raw data of all trials cited in drug licensing applications and …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL